Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment

Therapeutic advance in progressive multiple sclerosis (MS) has been very slow. Based on the transformative role magnetic resonance imaging (MRI) contrast-enhancing lesions had on drug development for relapsing-remitting MS, we consider the lack of sensitive outcomes to be the greatest barrier for de...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Neurol
Autori principali: Kosa, Peter, Ghazali, Danish, Tanigawa, Makoto, Barbour, Chris, Cortese, Irene, Kelley, William, Snyder, Blake, Ohayon, Joan, Fenton, Kaylan, Lehky, Tanya, Wu, Tianxia, Greenwood, Mark, Nair, Govind, Bielekova, Bibiana
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2016
Soggetti:
Neuroscience
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4983704/
https://ncbi.nlm.nih.gov/pubmed/27574516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2016.00131
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi